#巴西交易所b3拟2027年上半年推出证券代币化平台 U.S. Market Close: Dow Jumps Over 400 Points, Moderna Soars 14%, Lumentum Says It’s “Sold Out Through 2029”
All three major U.S. stock indexes closed higher on Friday. The Dow rose 0.83% to 51,654.95, the Nasdaq gained 0.64%, and the S&P 500 rose 0.59%.
By trading value, Micron led the market but fell 0.66%. Nvidia dropped 0.52%, SpaceX gained 1.25%, Tesla rose 2.05%, and Apple fell more than 1%.
Two highlights today: Moderna surged 14.21% after officially joining the Nasdaq 100 Index, reaching its highest share price since December 2022. Lumentum rose 5.22%. Its CEO acknowledged that the company is “completely sold out, with no end in sight.” Some products are still facing a 30% shortfall in 2028, and the sellout timeline has moved up by nearly a year.
Palantir gained 5.17% to hit a record high, with both Goldman Sachs and Barclays bullish on the stock and a top price target of $265. Microsoft rose 2.38% after launching a fast-reasoning AI model that is 35 times faster than GPT-6 Sol.
Summary: Indexes rose broadly, but performance varied significantly, with AI infrastructure and biotech leading the way. Market sentiment was upbeat, but Apple’s order cuts and weakness in AMD and Intel show that investors are being selective—not buying everything indiscriminately.
All three major U.S. stock indexes closed higher on Friday. The Dow rose 0.83% to 51,654.95, the Nasdaq gained 0.64%, and the S&P 500 rose 0.59%.
By trading value, Micron led the market but fell 0.66%. Nvidia dropped 0.52%, SpaceX gained 1.25%, Tesla rose 2.05%, and Apple fell more than 1%.
Two highlights today: Moderna surged 14.21% after officially joining the Nasdaq 100 Index, reaching its highest share price since December 2022. Lumentum rose 5.22%. Its CEO acknowledged that the company is “completely sold out, with no end in sight.” Some products are still facing a 30% shortfall in 2028, and the sellout timeline has moved up by nearly a year.
Palantir gained 5.17% to hit a record high, with both Goldman Sachs and Barclays bullish on the stock and a top price target of $265. Microsoft rose 2.38% after launching a fast-reasoning AI model that is 35 times faster than GPT-6 Sol.
Summary: Indexes rose broadly, but performance varied significantly, with AI infrastructure and biotech leading the way. Market sentiment was upbeat, but Apple’s order cuts and weakness in AMD and Intel show that investors are being selective—not buying everything indiscriminately.